#biopharma

19:01 27.01.2021

Biopharma starts production of potentially effective drug against COVID-19

11:40 24.12.2020

Biopharma plans to invest $20-23 mln in development of plasma centers network by 2025

16:55 14.11.2020

Biopharma Plasma head announces world's first completion of clinical trials of immunoglobulin used COVID-19 treatment

12:50 05.08.2020

Biopharma collects about half of plasma required for production of experimental batch of cure for COVID-19

16:25 18.05.2020

Biopharma starts conducting tests of all donors for availability of COVID-19 antibody assay

18:29 11.12.2019

STADA CEO: We plan to expand our Biopharma product line

10:25 02.12.2019

Germany's STADA buying Biopharma's pharmaceutical business of prescription, OTC preparations

16:43 16.08.2019

$Biopharma blood preparations producer to officially open fractionator plant in Kyiv region late Sept$

Biopharma blood preparations producer to officially open fractionator plant in Kyiv region late Sept

16:58 25.02.2019

Biopharma starts commissioning work at new plant in Kyiv region

17:21 15.01.2019

Darnitsa pharma firm replaces director general

17:17 27.07.2018

Biopharma intends to open four plasma centers in Ukraine in near future

PRESS RELEASES

Forum “Bread Industry - 2025” in Uman: the main market event that shapes the vector of changes

Presentation of the new ForUA information portal

AmCham Ukraine Calls on Government and Members of Parliament to Prevent Reintroduction of Export Duties on Oilseeds

PRESS CONFERENCES

Instead of refuting individual elements of propaganda, we need to create holistic picture of the world, where enemy narratives lose their meaning - discussion on information defense